A novel CYLD germline mutation in Brooke-Spiegler syndrome

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 3, 2015, Pages 457-462

  Guardoli, D ^a   Argenziano, G ^a   Ponti, G ^b   Nasti, S ^c   Zalaudek, I ^d   Moscarella, E ^a   Lallas, A ^a   Piana, S ^a   Specchio, F ^e   Martinuzzi, C ^c   Raucci, M ^a   Pellacani, G ^b   Longo, C ^a  

^a Palliative Care Unit IRCCS Arcispedale S Maria Nuova   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYLINDROMATOSIS PROTEIN; PEPTIDES AND PROTEINS; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; CYLD PROTEIN, HUMAN; PARAFFIN; TUMOR SUPPRESSOR PROTEIN;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BROOKE SPIEGLER SYNDROME; CASE REPORT; CLINICAL EXAMINATION; CODON; DNA EXTRACTION; ENZYME ACTIVE SITE; EXON; FAMILY HISTORY; FEMALE; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIDDLE AGED; PAPULE; PHENOTYPE; PRIORITY JOURNAL; SCALP TUMOR; SKIN TUMOR; SOMATIC MUTATION; TRICHOEPITHELIOMA; FAMILIAL CANCER; GENETICS; GERMLINE MUTATION; MALE; PEDIGREE;

FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PARAFFIN EMBEDDING; PEDIGREE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84923068909     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12578     Document Type: Article

References (60)

1. Szepietowski JC, Wasik F, Szybejko-Machaj G, Bieniek A, Schwartz RA,. Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol 2001; 15: 346-349.
2. Gerretsen AL, Van der Putte SC, Deenstra W, Van Vloten WA,. Cutaneouscylindroma with malignant transformation. Cancer. 1993; 72: 1618-1623. Review.
3. Kim C, Kovich OI, Dosik J,. Brooke-Spiegler syndrome. Dermatol Online J 2007; 13: 10.
4. Singh DD, Naujoks C, Depprich R, et al,. Cylindroma of head and neck: review of the literature and report of two rare cases. J Craniomaxillofac Surg 2013; 41: 516-521.
5. Manchanda K, Bansal M, Bhayana AA, Pandey S,. Brooke-spieglersyndrome: a rare entity. Int J Trichology 2012; 4: 29-31.
6. Kazakov DV, Soukup R, Mukensnabl P, Boudova L, Michal M,. Brooke-Spiegler syndrome: report of a case with combined lesions containing cylindromatous, spiradenomatous, trichoblastomatous, and sebaceous differentiation. Am J Dermatopathol 2005; 27: 27-33.
7. Ly H, Black MM, Robson A,. Case of the Brooke-Spiegler syndrome. Australas J Dermatol 2004; 45: 220-222.
8. Korting HC, Konz B,. Coincidence of multiple cylindroma and trichoepitheliomas (Brooke-Spiegler-Syndrome). Hautarzt 1982; 33: 34-46.
9. Saunders H, Tucker P, Saurine T, Watkins F,. Pedigree of multiple benign adnexal tumours of Brooke-Spiegler type. Australas J Dermatol 2003; 44: 144-148.
10. Weyers W, Nilles M, Eckert F,. Schill WB.:- Spiradenomas inBrooke-Spiegler syndrome. Am J Dermatopathol 1993; 15: 156-161.
11. Uede K, Yamamoto Y, Furukawa F,. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma, spiradenoma, and syringoma. J Dermatol 2004; 31: 32-38.
12. Delfino M, D'Anna F, Ianniello S, Donofrio V,. Multiple hereditary trichoepithelioma and cylindroma (Brooke-Spiegler syndrome). Dermatologica 1991; 183: 150-153.
13. Burrows NP, Jones RR, Smith NP,. The clinicopathological features of familial cylindromas and trichoepitheliomas (Brooke-Spiegler syndrome): a report of two families. Clin Exp Dermatol 1992; 17: 332-336.
14. Jungehülsing M, Wagner M, Damm M,. Turban tumour with involvement of the parotid gland. J Laryngol Otol 1999; 113: 779-783. Review.
15. Evans CD,. Turban tumour. Br J Dermatol 1954; 66: 434-443.
16. Kakagia D, Alexiadis G, Kiziridou A, Lambropoulou M,. Brooke-Spieglersyndrome with parotid gland involvement. Eur J Dermatol 2004; 14: 139-141.
17. Kalina P, El-Azhary R,. Brooke-spiegler syndrome with multiple scalp cylindromas and bilateral parotid gland adenomas. Case Rep Radiol 2012; 2012: 249583.
18. Kazakov DV, Benkova K, Michal M, Vanecek T, Kacerovska D, Skalova A,. Skin type spiradenoma of the parotid gland with malignant transformation: report of a case with analysis of the CYLD gene. Hum Pathol 2009; 40: 1499-1503.
19. Grossmann P, Vanecek T, Steiner P, et al,. Novel and recurrent germline and somatic mutations in cohort of 67 patients from 48 families with Brooke-Spieglersyndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol 2013; 35: 34-44.
20. Hu G, Onder M, Gill M, et al,. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J Invest Dermatol 2003; 121: 732-734.
21. Nagy N, Farkas K, Kinyo A, et al,. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome. Exp Dermatol 2012; 21: 967-969.
22. Biggs PJ, Wooster R, Ford D, et al,. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet 1995; 11: 441-443.
23. Bowen S, Gill M, Lee DA, et al,. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol 2005; 124: 919-920.
24. Biggs PJ, Chapman P, Lakhani SR, Burn J,. Stratton MR: the cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene 1996; 12: 1375-1377.
25. Bignell GR, Warren W, Seal S, et al,. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000: 25; 160-165.
26. Kazakov DV, Schaller J, Vanecek T, Kacerovska D, Michal M,. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors. J Cutan Pathol 2010; 37: 886-890.
27. Fenske C, Banerjee P, Holden C, Carter N,. Brooke-Spiegler syndrome locus assigned to 16q12-q13. J Invest Dermatol 2000; 114: 1057-1058.
28. Scheinfeld N, Hu G, Gill M, Austin C, Celebi JT,. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome. Clin Exp Dermatol 2003; 28: 539-541.
29. Melly L, Lawton G, Rajan N,. Basal cell carcinoma arising in association with trichoepithelioma in a case of Brooke-Spiegler syndrome with a novel genetic mutation in CYLD. J Cutan Pathol 2012; 39: 977-978.
30. Heinritz W, Grunewald S, Strenge S, et al,. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene. Br J Dermatol 2006; 154: 992-994.
31. Rajan N, Langtry JA, Ashworth A, et al,. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction. Arch Dermatol 2009; 145: 1277-1284.
32. Kazakov DV, Vanecek T, Zelger B, et al,. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol 2011; 33: 251-65.
33. van den Ouweland AM, Elfferich P, Lamping R, et al,. Identification of a largerearrangement in CYLD as a cause of familial cylindromatosis. Fam Cancer 2011; 10: 127-132. doi: 10.1007/s10689-010-9393-y.
34. Sima R, Vanecek T, Kacerovska D, et al,. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn Mol Pathol 2010; 19: 83-91.
35. Scholz IM, Nümann A, Froster UG, Helmbold P, Enk AH, Näher H,. New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome. J Dtsch Dermatol Ges 2010; 8: 99-101.
36. Almeida S, Maillard C, Itin P, Hohl D, Huber M,. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 2008; 128: 587-593. Epub 2007 Sep 13.
37. Amaro C, Freitas I,. Lamarão P, Afonso A, Skrzypczak M, Heinritz W.: Multiple trichoepitheliomasâ€"a novel mutation in the CYLD gene. J Eur Acad Dermatol Venereol 2010; 24: 844-846.
38. Kazakov DV, Thoma-Uszynski S, Vanecek T, Kacerovska D, Grossmann P, Michal M,. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Am J Dermatopathol 2009; 31: 664-673.
39. Saggar S, Chernoff KA, Lodha S, et al,. CYLD mutations in familial skin appendage tumours. J Med Genet 2008; 45: 298-302. doi: 10.1136/jmg.2007.056127. Epub 2008 Jan 30.
40. Kazakov DV, Vanecek T, Nemcova J, et al,. Spectrum of tumors with follicular differentiation in a patient with the clinical phenotype of multiple familial trichoepitheliomas: a clinicopathological and molecular biological study, including analysis of the CYLD and PTCH genes. Am J Dermatopathol 2009; 31: 819-827.
41. Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK,. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 2007; 28: 21-27.
42. Strobel P, Zettl A, Ren Z, et al,. Spiradenocylindroma of the kidney: Clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm. Am J Surg Pathol 2002; 26: 119-124.
43. Hirai Y, Kawamata Y, Takeshima N, et al,. Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix. Int J Oncol 2004; 24: 977-986.
44. Lallas A, Apalla Z, Tzellos T, Lefaki I,. Dermoscopy of solitary cylindroma. Eur J Dermatol 2011; 21: 645-646.
45. Cabo H, Pedrini F, Cohen Sabban E,. Dermoscopy of cylindroma. Dermatol Res Pract 2010; 2010: 285392.
46. Jarrett R, Walker L, Bowling J,. Dermoscopy of Brooke-Spiegler syndrome. Arch Dermatol 2009; 145: 854.
47. Akgul GG, Yenidogan E, Dinc S, Pak I, Colakoglu MK, Gulcelik MA,. Malign cylindroma of the scalp, with multiple cervical lymph node metastasis-A case report. Int J Surg Case Rep 2013; 4: 589-592.
48. Durani BK, Kurzen H, Jaeckel A, Kuner N, Naeher H, Hartschuh W,. Malignant transformation of multiple dermal cylindromas. Br J Dermatol 2001; 145: 653-656.
49. Richmond HM, Duvic M, Macfarlane DF,. Primary and metastatic malignant tumors of the scalp: an update. Am J Clin Dermatol 2010; 11: 233-246.
50. Lin PY, Fatteh SM, Lloyd KM,. Malignant transformation in a solitary dermal cylindroma. Arch Pathol Lab Med 1987; 111: 765-767.
51. Lotem M, Trattner A, Kahanovich S, Rotem A, Sandbank M,. Multiple dermal cylindroma undergoing a malignant transformation. Int J Dermatol 1992; 31: 642-644.
52. Sicinska J, Rakowska A, Czuwara-Ladykowska J, et al,. Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome. J Dermatol Case Rep 2007; 1: 4-9. doi: 10.3315/jdcr.2007.1.1002.
53. Kazakov DV, Zelger B, Rütten A, et al,. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol 2009; 33: 705-19.
54. Pizinger K, Michal M,. Malignant cylindroma in Brooke-Spiegler syndrome. Dermatology 2000; 201: 255-257.
55. De Francesco V, Frattasio A, Pillon B, et al,. Carcinosarcoma arising in a patient with multiple cylindromas. Am J Dermatopathol 2005; 27: 21-26.
56. Ponti G, Nasti S, Losi L, et al,. Bianchi Scarrà G, Seidenari S.: Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. J Cutan Pathol 2012; 39: 366-371.
57. Grossmann P, Vanecek T, Steiner P, et al,. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol 2013; 35: 34-44.
58. Ponti G, Ruini C, Girolomoni G, et al,. Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor. Future Oncol 2014: 10: 345-350.
59. Nasti S, Pastorino L, Bruno W, et al,. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas. Clin Genet 2009; 76: 481-485.
60. Sima R, Vanecek T, Kacerovska D, et al,. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn Mol Pathol 2010; 19: 83-91.